Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 4, 2000
Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomyT Irie, J Kigawa, Y Minagawa, et al.
Human Cell|January 5, 2002
p53 gene status and chemosensitivity in ovarian cancerJ Kigawa, S Sato, M Shimada, et al.
Cancer Letters|July 31, 1998
Irinotecan (CPT-11) combined with cisplatin in patients with refractory or recurrent ovarian cancerT Sugiyama, M Yakushiji, T Nishida, et al.
Japanese Journal of Cancer Research : Gann|February 25, 1998
Enhanced topoisomerase I activity and increased topoisomerase II alpha content in cisplatin-resistant cancer cell linesY Minagawa, J Kigawa, T Irie, et al.
Asia-Oceania Journal of Obstetrics and Gynaecology|September 1, 1990
Massive fetomaternal hemorrhage: case reportH Ishihara, H Takahashi, Y Takeuchi, et al.
Cancer|February 1, 1997
Glutathione S-transferase-pi expression and glutathione concentration in ovarian carcinoma before and after chemotherapyX Cheng, J Kigawa, Y Minagawa, et al.
Oncology|October 21, 1998
Residual disease and presence of human papillomavirus after conizationY Kanamori, J Kigawa, Y Minagawa, et al.
Nihon Sanka Fujinka Gakkai Zasshi|October 1, 1996
[Quality of life in patients with advanced ovarian cancer who underwent cytoreductive surgery followed by chemotherapy]S Tei, J Kigawa, M Okada, et al.
Cancer|February 26, 1998
Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancerJ Kigawa, Y Minagawa, Y Kanamori, et al.
Gynecologic Oncology|August 12, 1998
Indication and efficacy of radiation therapy following radical surgery in patients with stage IB to IIB cervical cancerM Okada, J Kigawa, Y Minagawa, et al.
Pageof 7